Designed to enhance the safety and security of the United States pharmaceutical supply chain, the DSCSA plays a critical part in safeguarding patients by ensuring drug supply chain integrity. This is accomplished through interoperable, electronic package tracing, annual licensure reports from wholesale distributors and third-party logistics providers, and other regulatory tools that aide in the detection and removal of dangerous drugs from the supply chain.

Join industry thought leader(s) as they discuss DSCSA initiatives to prioritize patient well-being and supply chain integrity in collaboration with the Food and Drug Administration (FDA). Break down obstacles to patient safety such as counterfeit, stolen, or contaminated drugs including recalls and how these obstacles can be overcome.

Learning Objectives
1. Define how scanning the DSCSA Product Identifier enhances patient safety at your IDN. 
2. Outline methods of ensuring security within the pharmacy supply chain that suggest focus on FDA’s recent final guidance” and compliance policy “Enhanced Drug Distribution Security Requirements.”
3. Review the FDA’s latest final guidance on verification systems under DSCSA that manufacturers, repackagers, wholesale distributors and dispensers must have in place for potential future threats to the integrity of your pharmacy supply chain.
4. Discuss methods for confirming the entities you do business with are licensed or registered.

View Slides

Listen to Audio